SLC7A5 and cancer: Thus, the effects of LAT1-inhibitors on LAT1 expression on the BBB as well as on cancer cells should be studied more thoroughly with more accurate quantitative proteomic methods, such as with LC-MS/MS in future to estimate the real long-term efficacy of LAT1-inhibitor treatment and the possibility of adaptive drug resistance towards the compounds.